The Business of Fashion
Agenda-setting intelligence, analysis and advice for the global fashion community.
Agenda-setting intelligence, analysis and advice for the global fashion community.
Estée Lauder lowered its annual organic sales estimate on persistent softness in Mainland China’s prestige beauty space, even as a demand rebound in the US and Asia-Pacific markets drove a profit forecast raise.
Shares of the New York-based company dropped 5 percent in pre-market trading on Wednesday.
Estée also beat Wall Street targets for third-quarter results, hinting at a recovery in demand for beauty and cosmetic products in the US after a long bout of inflation had pressured sales of luxury items in the world’s biggest economy.
A pick-up in China demand after several quarters of weakness also underscored customer willingness to splurge on “affordable luxuries” such as fragrances and make-up products.
ADVERTISEMENT
“Estée Lauder’s management might have taken the view it is better to be cautious now and over-deliver, than continue with high expectations and fail to sell enough products,” said Dan Coatsworth, investment analyst at AJ Bell.
The company expects annual organic sales to fall 1 percent to 2 percent, compared with its previous forecast for a 1 percent decrease to a 1 percent increase.
Third-quarter organic net sales in the Americas grew 1 percent, with a 3 percent rise in the Asia Pacific region.
Last month, European rival L’Oréal also beat sales expectations and eased concerns about waning demand in the US and China - the two biggest beauty markets.
“The sector has held better than I expected and the question really around luxury and personal luxury goods is whether 2024 will be a hard or soft landing ... so far it speaks to the narrative of a soft landing,” said Javier Gonzalez Lastra, luxury-focused portfolio manager at Tema ETFs.
Estée now expects full-year 2024 adjusted profit per share between $2.14 and $2.24, compared with a prior forecast of $2.08 to $2.23.
Net sales rose 5 percent to $3.94 billion, compared with LSEG estimates of $3.91 billion. Adjusted profit of 97 cents per share surpassed expectations of 49 cents.
By Ananya Mariam Rajesh; Editing by Devika Syamnath
ADVERTISEMENT
Learn more:
Estée Lauder’s Big New Skincare Bet Is Like The Ordinary – at Six Times the Price
Deciem’s other skincare brand, NIOD, also sells serums with names straight out of a lab, but with more complex formulations and higher-spec packaging. A decade into the science-backed skincare craze, the company believes its consumers are ready to move upmarket.
The showcase translated the company’s global insights consumer study into scent profiles, technologies and fragrances.
The Estée Lauder-owned premium fragrance house has signed a two-year deal with the actor in a bet to seize more of the men’s market.
From medspas to telemedicine, weight loss drugs are becoming adopted for mainstream cosmetic use.
Mature consumers have long been ignored by the beauty industry. Now a small but growing number of emerging brands are responding to the needs of those over the age of 45 in a bid to cash in on their $15 trillion spending power.